NF-κB is constitutively activated in pancreatic cancer cells which is due in part to the presence of mutated KRAS. Microsclerodermin A inhibited NF-κB transcription which may be regulated by GSK-3β activity. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.